LifeCell gets DCGI nod for clinical trial of cell therapy to treat COVID patients
Leading stem cell bank LifeCell on Thursday said it has received approval from the Drug Controller General of India (DCGI) for a clinical trial of Mesocel.
Leading stem cell bank LifeCell on Thursday said it has received approval from the Drug Controller General of India (DCGI) for a clinical trial of Mesocel.
